.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Chubb
Farmers Insurance
McKinsey
Deloitte
Moodys
Cerilliant
Fuji
Colorcon
Julphar

Generated: December 13, 2017

DrugPatentWatch Database Preview

COLESTID Drug Profile

« Back to Dashboard

When do Colestid patents expire, and when can generic versions of Colestid launch?

Colestid is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.

The generic ingredient in COLESTID is colestipol hydrochloride. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.
Drug patent expirations by year for COLESTID

Pharmacology for COLESTID

Medical Subject Heading (MeSH) Categories for COLESTID

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Pharmacia And UpjohnCOLESTIDcolestipol hydrochlorideGRANULE;ORAL017563-003Sep 22, 1995ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Pharmacia And UpjohnCOLESTIDcolestipol hydrochlorideGRANULE;ORAL017563-004Sep 22, 1995ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Pharmacia And UpjohnCOLESTIDcolestipol hydrochlorideTABLET;ORAL020222-001Jul 19, 1994ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for COLESTID

Drugname Dosage Strength RLD Submissiondate
colestipol hydrochlorideTablets1 gColestid8/23/2005

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
QuintilesIMS
Harvard Business School
Johnson and Johnson
Argus Health
Teva
Julphar
Chinese Patent Office
Cantor Fitzgerald
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot